EDRH
CRL icon

Edmond de Rothschild Holding’s Charles River Laboratories CRL Stock Holding History

Edmond de Rothschild Holding’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,355
Closed -$1.55M – 712
2023
Q2 		$1.55M Sell
7,355
-1,194
-14% -$238K 0.03% 285
2023
Q1 		$1.73M Buy
8,549
+1,167
+16% +$264K 0.04% 271
2022
Q4 		$1.61M Sell
7,382
-157
-2% -$34.3K 0.04% 274
2022
Q3 		$1.48M Buy
+7,539
New +$1.63M 0.04% 274

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Edmond de Rothschild Holding's CRL Position: Q3 2023 in Review

Edmond de Rothschild Holding sold out of Charles River Laboratories (CRL) in Q3 2023, closing a stake of 7,355 shares — an estimated $1.55M sold.

Edmond de Rothschild Holding first reported a position in CRL in Q3 2022 and held it in 4 quarters. The position peaked at $1.73M in Q1 2023. 621 funds tracked by Wall St. Rank hold CRL as of Q3 2023.

  • Edmond de Rothschild Holding reported no remaining Charles River Laboratories position as of Q3 2023 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 7,355 Charles River Laboratories shares in Q3 2023, an estimated $1.55M.
  • Edmond de Rothschild Holding first reported a position in Charles River Laboratories in Q3 2022 and held it in 4 quarters.
  • Edmond de Rothschild Holding's Charles River Laboratories position peaked at $1.73M in Q1 2023.
  • 621 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2023.

Based on Edmond de Rothschild Holding's 13F filing for Q3 2023, filed 13 Nov 2023.